Nasus Pharma Ltd Increase (Decrease) in Accounts Payable
Nasus Pharma Ltd (NSRX) reported Increase (Decrease) in Accounts Payable of $152.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-03-25
| Period end | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|
| 2025-12-31 | $152.00K 20-F · filed 2026-03-25 | |
| 2025-06-30 | $13.00K 6-K · filed 2025-12-29 | |
| 2024-12-31 | -$5.00K 20-F · filed 2026-03-25 | |
| 2024-06-30 | -$4.00K 6-K · filed 2025-12-29 | |
| 2023-12-31 | -$116.00K 20-F · filed 2026-03-25 |